LOCAL PROVIDER DIRECTORY
Find a dentist
Search by name or specialty, then choose a city and region or enter a ZIP / postal code.
Choose a location to keep your results local.
Local Health Alerts
Bicillin L-A shortage continues, CDC says
The CDC says the Bicillin L-A shortage is still ongoing, and that matters because this is the preferred penicillin treatment for syphilis in pregnancy. Officials say limited supply should be preserved for pregnant patients whenever possible, while some areas may also use temporarily…
FDA’s updated “healthy” label could change packaged food choices
The FDA has updated the meaning of “healthy” on packaged foods so the claim better matches current nutrition science and federal dietary guidance. The label may help shoppers compare products, but it is not a guarantee of low calories, minimal processing, or the…
Colorectal cancer screening stays in focus for adults 45 to 75
New CDC and CMS guidance keeps colorectal cancer screening front and center for adults ages 45 to 75. The main message is simple: screening is for people who do not have symptoms, and the right test depends on age, risk, access, and follow-up…
FDA tightens oversight of compounded GLP-1 prescriptions as supply stabilizes
FDA is narrowing the path for compounded GLP-1 prescriptions as national supply stabilizes. Patients using these medicines should check whether their product is FDA-approved, compounded, or made from a bulk substance, because the rules and safety concerns are not the same.
Which vaccines should adults review this season, and who may still need a catch-up dose?
Spring is a good time for adults to check vaccine records, especially after CDC updated pneumococcal and meningococcal guidance this year. Some adult vaccines are based on age, some on medical risk, and some need regular timing such as flu shots or a…
Why personalized breast cancer screening is drawing more attention
A large U.S. trial is putting risk-based breast cancer screening in the spotlight. The main takeaway for readers: it looks promising, but it has not replaced current screening guidance, and people should not change their schedule on their own.
Could risk-based breast cancer screening replace yearly mammograms for some women?
A large U.S. trial suggests breast cancer screening could one day be tailored to a woman’s individual risk instead of using the same schedule for everyone. The approach looked promising, but experts say it is not ready to replace routine screening on its…
Medicare speeds up coverage reviews for some breakthrough devices
CMS and FDA have announced RAPID, a new pathway meant to shorten Medicare coverage decisions for certain breakthrough medical devices. The change could help some patients get access sooner, but it applies only to a narrow set of devices and still depends on…
FDA recalls of injectable fluids raise a practical safety question
A late-April FDA recall of B. Braun Lactated Ringer’s Injection is mainly a hospital supply issue, but it can matter for patients who may have received the affected IV fluid. The key questions are whether a facility used one of the recalled lots,…
Measles cases are still rising in the U.S. What readers should know about symptoms, exposure, and when to call a doctor
U.S. measles activity remains elevated, and public health officials say the disease is still spreading in outbreaks in multiple states. For readers, the practical takeaway is simple: know the early symptoms, check vaccination status, and act quickly after a known exposure. Measles is…
What CDC’s newest advice says about added sugar
CDC refreshed its nutrition pages in March and April 2026 with a simple message: most Americans still get too much added sugar, and sugary drinks are a major source. The agency’s updated label guidance is meant to help families spot added sugars, compare…
CMS and FDA Launch RAPID Pathway for Breakthrough Devices
CMS and the FDA have created a new Medicare coverage pathway aimed at speeding access to certain breakthrough medical devices. The first practical effect is a faster route to a proposed Medicare coverage decision after FDA authorization, but many details still depend on…
